Skip to main content
. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443

Figure 2.

Figure 2

(A) 18F-fluorodeoxyglucose (FDG) by positron emission tomography (PET) activity and improvement in pulmonary function. Correlation between high activity of pulmonary parenchyma on 18F-FDG PET (maximum standardized uptake value [SUVmax]) at baseline and improvement in forced vital capacity (FVC) in patients with a pulmonary treatment indication (R = 0.62, p = 0.0004). Reproduced and modified from (134) with permission. (B) Example of a PET-CT scan of a sarcoidosis patient with pulmonary involvement, before (i) and after (ii) 6 months of infliximab therapy.